InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,952.00
(
-0.19%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.74
(
0.23%
)
Bitcoin
57,258.27
(
-1.68%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 245910

Monday, 03/27/2023 1:26:44 PM

Monday, March 27, 2023 1:26:44 PM

Post# of 251670
JNCE accepts_sweetened_buyout_offer_from_Concentra_Biosciences—(Tang Capital)—$1.85/sh cash +CVR:

https://www.globenewswire.com/news-release/2023/03/27/2634797/0/en/Jounce-Therapeutics-Enters-Into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-for-1-85-in-Cash-per-Share-Plus-Contingent-Value-Rights.html

The accepted offer is $0.05/sh better than Tang’s Capital’s offer on 3/14/23 (#msg-171445879) and is a 68% premium (exluding any value for the CVR) to JNCE’s “unaffected” share price on 2/23/23 prior to announcement of the all-stock reverse-merger with REDX.L, which is now defunct (#msg-171282176).

In an odd twist, JNCE is implementing an 84% layoff in conjunction with the merger.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up